Tenax Therapeutics is trading 6% up at $1.97 after closing at $1.85 on September 2, 2026; the catalyst remains unclear, though provided price context shows a 6.49% after-hours gain.
- The September 1 announcement concerned a September 9 Cantor Global Healthcare Conference presentation.
- Recent LEVEL trial data had already been released, while broader markets were modestly higher.